Becton Dickinson and Company 

$48.16
6
+$0.66+1.39% Wednesday 20:00

统计

当日最高
-
当日最低
-
52周高点
-
52周低点
-
成交量
-
平均成交量
-
市值
13.69B
市盈率
0
股息率
-
股息
-

即将到来

股息

0%股息率
Sep 25
$0.75
Jun 25
$0.75
Mar 25
$0.75
Dec 24
$0.75
Sep 24
$0.75
10年增长
不适用
5年增长
不适用
3年增长
13.43%
1年增长
-25%

财报

30Apr预期
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
下一步
2.21
2.79
3.38
3.96
预期EPS
2.775
实际EPS
不适用

财务

8.95%利润率
有盈利
2017
2018
2019
2020
2021
2022
18.87B营收
1.69B净利润

其他人也在关注

此列表基于在 Stock Events 上关注 BDXB 的用户自选生成。这不是投资建议。

竞争对手

此列表为基于近期市场事件的分析。并非投资建议。

关于

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral IV and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, IV fluids, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps and dedicated disposables, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. It has a strategic partnership with the Biomedical Advanced Research and Development Authority to develop new manufacturing lines for injection devices. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Show more...
首席执行官
Thomas Polen
员工
70000
国家
US
ISIN
US0758874061

上市

0 Comments

分享你的想法

FAQ

Becton Dickinson and Company 今天的股价是多少?
BDXB 当前价格为 $48.16 USD,过去 24 小时上涨了 +1.39%。在图表上更密切关注 Becton Dickinson and Company 股价表现。
Becton Dickinson and Company 的股票代码是什么?
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Becton Dickinson and Company 的股票以代码 BDXB 进行交易。
Becton Dickinson and Company 的市值是多少?
今天 Becton Dickinson and Company 的市值为 13.69B
Becton Dickinson and Company 去年的营收是多少?
Becton Dickinson and Company 去年的营收为 18.87BUSD。
Becton Dickinson and Company 去年的净利润是多少?
BDXB 去年的净收益为 1.69BUSD。
Becton Dickinson and Company 会发放股息吗?
是的,BDXB 的股息每 每季度 发放一次。每股最新股息为 0.75 USD。截至今日,股息率(FWD)% 为 0%。
Becton Dickinson and Company 有多少名员工?
截至四月 03, 2026,公司共有70,000名员工。
Becton Dickinson and Company 属于哪个行业?
Becton Dickinson and Company从事于Manufacturing行业。
Becton Dickinson and Company 何时完成拆股?
Becton Dickinson and Company 最近没有进行任何拆股。
Becton Dickinson and Company 的总部在哪里?
Becton Dickinson and Company 的总部位于 US 的 Franklin Lakes。